Tech Company Financing Transactions

StrataGent Life Sciences Funding Round

StrataGent Life Sciences, based in Los Gatos, received $16 million from EW Healthcare Partners and Quantum Technology Partners.

Transaction Overview

Announced On
5/10/2007
Transaction Type
Venture Equity
Amount
$16,000,000
Round
Series B
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
16301 Withey Rd
Los Gatos, CA 95030
USA
Email Address
Overview
The company is developing non-invasive versions of drugs that would otherwise be injected.
Profile
StrataGent Life Sciences LinkedIn Company Profile
Social Media
StrataGent Life Sciences Company Twitter Account
Company News
StrataGent Life Sciences News
Facebook
StrataGent Life Sciences on Facebook
YouTube
StrataGent Life Sciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Robert Thomas
  Robert Thomas LinkedIn Profile  Robert Thomas Twitter Account  Robert Thomas News  Robert Thomas on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/10/2007: Bioabsorbable Therapeutics venture capital transaction
Next: 5/10/2007: Synovis Orthopedic and Woundcare venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record every notable VC transaction. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary